VENTYX BIOSCIENCES, INC. VTYX 深 滬
等待開盤 12-12 09:30:00 美东时间
8.50
-0.190
-2.19%
華盛通- 最 高8.70
- 今 開8.60
- 成交量 88.18万股
- 最 低 8.441
- 昨 收 8.69
- 總市值 6.06亿
- 52周最高 10.548
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.783
- 委 比 78.78%
- 總股本 7130.85万
- 歷史最高 47.2508
- 量 比 0.48
- 振 幅 2.98%
- 歷史最低 0.783
- 每 手 1
- 風險率 2.39%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Ventyx Pushes Heart Drug Trial Results to 2026 to Test New "Once-Daily" Pill, Taps Heavyweight Advisors, Including CEO Behind $11B Merck Deal
Ventyx Biosciences, Inc. (NASDAQ:VTYX) ("Ventyx", "Company"), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with inflammation-mediated cardiovascular and
12-02 20:07
Analyst Sees Value In Neumora's Expanding Obesity And Metabolic Pipeline
RBC upgrades Neumora, citing strong early NLRP3 obesity data and growing pipeline momentum ahead of key 2026 readouts.
12-02 02:45
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
11-10 10:22
美股大行评级 | 最高325美元！10家机构集体上调AMD目标价；Pinterest遭14家大行下调目标价；大行对优步目标价分歧大，5家下调5家上调
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从3美元升至9美元；HC Wainwright & Co.：上调CervoMed评级至"买入"，目标价从11美元升至25美元
11-06 09:55
HC Wainwright & Co. Upgrades Ventyx Biosciences to Buy, Announces $18 Price Target
HC Wainwright & Co. analyst Emily Bodnar upgrades Ventyx Biosciences (NASDAQ:VTYX) from Neutral to Buy and announces $18 price target.
11-05 19:24
美股大行评级 | 买入！Fermi、Neptune获多家大行首予评级；伯克希尔哈撒韦罕见地获得“卖出”评级；摩根大通上调苹果目标价升至290美元
今日重点评级关注：Guggenheim：上调Neumora Therapeutics评级至"买入"，目标价14美元；韦德布什：上调Fate Therapeutics评级至"跑赢大市"，目标价从5美元升至7美元
10-28 10:08
美股牛股 | VTYX大涨71%！新药研究取得积极结果；SEV转型为公益公司，涨近58%
VTYX大涨71%！新药在肥胖和心血管风险因素患者中的2期研究取得积极结果；SEV转型为公益公司，涨近58%>>
10-24 15:16
Ventyx Stock Is Rallying Thursday: What's Driving The Surge?
Ventyx Biosciences Inc (NASDAQ:VTYX) shares are surging Thursday after the company announced positive Phase 2 study results for VTX3232.
10-24 01:40
What's Driving Beyond Meat's 11% After-Hours Drop?
Beyond Meat shares fell 11% after hours following a volatile rally sparked by ETF inclusion and short-selling activity.
10-23 13:50
